VIIV HEALTHCARE UK LIMITED

Active
Company number 06990358Private limited companyIncorporated 2009

Key figures

£5,701,089,000-3.5%
Net assets 2025
-3.5%
Average annual change 2024–2025
02 bn4 bn6 bn20242025

† VIIV HEALTHCARE UK LIMITED filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.

VIIV HEALTHCARE UK LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025

Sector comparison

SIC 46460

Where the company stands among the 2,974 active companies whose first SIC code is 46460 (Wholesale of pharmaceutical goods).

Net assets£5,701,089,000
Higher than 99% · median £32,520
Total assets£7,015,101,000
Higher than 99% · median £255,000
Employees277
Higher than 99% · median 1
Company age17.2 years
Older than 79% · median 6.2 years
Largest in this sector by net assets
  1. CSL BEHRING HOLDINGS LIMITED£11bn
  2. VIIV HEALTHCARE UK LIMITED£5.7bn
  3. MCKESSON GLOBAL SOURCING LIMITED£1bn
  4. MCKESSON MEDICAL-SURGICAL SOURCING LIMITED£999.5m
  5. PFIZER LIMITED£984m
  6. ABBOTT LABORATORIES LIMITED£871.8m
  7. GLAXOSMITHKLINE UK LIMITED£779m
  8. UNIKERIS LIMITED£642m
  9. HALEON UK TRADING LIMITED£554.8m
  10. MUNDIPHARMA MEDICAL COMPANY LIMITED£461.7m

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 2,974. The line on each bar marks the median.

Summary: VIIV HEALTHCARE UK LIMITED

What kind of company is it?

VIIV HEALTHCARE UK LIMITED is a private limited company registered with Companies House under company number 06990358. It was incorporated on 13 Aug 2009. Its status is active. The registered office is in London (WC1A). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460), activities of head offices (70100), other professional, scientific and technical activities n.e.c. (74909), other business support service activities n.e.c. (82990).

How is the company doing financially?

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Profit for the year was £701,916,000. Net assets were £5,701,089,000, down 3.5% on the previous year. Total assets were £7,015,101,000 and total liabilities £1,314,012,000. The company had an average of 277 employees. Figures are available for 2 financial years (2024–2025).

How does it compare with similar companies?

Compared with 2,974 active companies whose first SIC code is 46460: By net assets it ranks higher than 99% of them (median £32,520). By total assets it ranks higher than 99% of them (median £255,000). By number of employees it ranks higher than 99% of them (median 1). It is older than 79% of them (median age 6.2 years).

Does it supply the public sector?

The company is named as a supplier in 5 public contract award notices from 3 public sector buyers since 2021. Contracts awarded to it alone have a combined published value of £13.6m. Its most frequent buyer is The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (2 contracts). 2 of the awards are shared with other suppliers, typically framework agreements.

What do public registers and reports show?

In its latest payment practices report it took an average of 46 days to pay suppliers, and 4% of invoices were not paid within agreed terms. Its gender pay gap report for 2025/26 shows median hourly pay for women 13.4% lower than for men. It has modern slavery statements on the government registry for 6 years.

Who runs and controls the company?

One person with significant control is registered.

When are its next filings due?

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 25 Aug 2027.

Filed accounts2024–2025
2024 †2025 †
Profit for the year—701,916,000
Total assets7,312,499,0007,015,101,000
Total liabilities1,404,385,0001,314,012,000
Net assets / total equity5,908,114,0005,701,089,000
Average number of employees276277

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Public contracts

5 contracts

VIIV HEALTHCARE UK LIMITED is named as a supplier in 5 public contract award notices from 3 public sector buyers since 2021. The 2 contracts awarded to it alone with a published value add up to £13.6m. 2 awards are shared with other suppliers and not counted in that total.

Contracts per year
Main buyers3
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
2 contracts · £13.6m
NHS England
2 contracts
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PS…
1 contract
Contracts
  1. HIV Medicines‡The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PS… · shared by 5 suppliers, up to £79,068,428 in total
  2. NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024‡NHS England · shared by 13 suppliers, up to £626,522,476 in total
  3. NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & provision of a service to supply over labelled PrEP an…‡NHS England · £1
  4. Maraviroc (Celsentri®)‡The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · £194,444
  5. NP91921x Triumeq‡The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · £13,357,797

From contract award notices on Contracts Finder (since 2016) and Find a Tender (since 2021), published by the Cabinet Office under the Open Government Licence v3.0. Values are as published by the buyer and usually cover the whole contract term; the total leaves out awards shared between several suppliers, where the published figure is a ceiling for all of them, placeholder values and single figures of £1 billion or more. Notices marked ‡ do not state a company number and were linked by an exact match on the registered name. Contracts below the publication thresholds and those of devolved buyers that publish elsewhere are not included.

Statutory reporting

Payment practices1 Jan 2026 – 30 Jun 2026
Average time taken to pay invoices
46 days
Invoices not paid within agreed terms
4%
Standard payment terms
0–60 days
Member of a payment code
No
  • Within 30 days 32%
  • 31 to 60 days 36%
  • After 60 days 32%
Earlier periods (7)
Period ending
Days to pay
Within 30 days
Late
31 Dec 2025
50
31%
5%
30 Jun 2025
50
35%
8%
31 Dec 2024
45
39%
7%
30 Jun 2024
54
32%
8%
31 Dec 2023
53
35%
6%
30 Jun 2023
55
32%
9%
31 Dec 2022
55
32%
10%

View the latest report on GOV.UK

Gender pay gap2025/26
Median hourly pay
women 13.4% lower
Mean hourly pay
women 8% lower
Median bonus pay
women 13.6% lower
Employer size
250 to 499 employees
Lower pay quarter68.8% womenLower middle70.1% womenUpper middle51.3% womenUpper pay quarter54% women
Earlier years (1)
Year
Median hourly pay
Mean hourly pay
2024/25
women 15% lower
women 9.4% lower

A positive gap means women's average hourly pay is lower than men's across the whole employer; it is not a comparison of pay for the same work. View on the Gender pay gap service

Modern slavery statements6
2026
Statement · summary on GOV.UK · group statement (GSK PLC)
2025
Statement · summary on GOV.UK · group statement (GSK PLC)
2024
Statement · summary on GOV.UK · group statement (GSK PLC)
Earlier years (3)
2023
Statement · summary on GOV.UK · group statement (GSK PLC)
2022
Statement · summary on GOV.UK · group statement (GSK PLC)
2021
Statement · summary on GOV.UK · group statement (GSK PLC)

Figures the company reported itself to the government's Check payment practices service, Gender pay gap service and Modern slavery statement registry (Open Government Licence v3.0). Only large companies and employers with 250 or more staff have to report, so most companies have nothing here.

History

4 events
  1. Financial year 2025 endedAccounts: net assets £5.7bn, 277 employees
  2. Financial year 2024 endedAccounts: net assets £5.9bn, 276 employees
  3. Viiv Healthcare Limited registered as a person with significant control
  4. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.